Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus	Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus	Recruiting	Early phase 1	2026-06-29		NCT06946485

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	164

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	Nanjing	China	3

Clinical trials